Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial-Reference-Cited by-同舟云学术

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Published:2017-03 Issue:3 Volume:18 Page:323-335
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Soulières Denis,Faivre Sandrine,Mesía Ricard,Remenár Éva,Li Shau-Hsuan,Karpenko Andrey,Dechaphunkul Arunee,Ochsenreither Sebastian,Kiss Laura Anna,Lin Jin-Ching,Nagarkar Raj,Tamás László,Kim Sung-Bae,Erfán Jozsef,Alyasova Anna,Kasper Stefan,Barone Carlo,Turri Sabine,Chakravartty Arunava,Chol Marie,Aimone Paola,Hirawat Samit,Licitra Lisa

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Head and neck cancer;Argiris;Lancet,2008

3. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma;Sacco;J Clin Oncol,2015

4. Immunotherapy for head and neck cancer: latest developments and clinical potential;Bauml;Ther Adv Med Oncol,2016

5. Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models;Hu;Cancer Res,2002

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors;Developmental Cell;2024-08

2. Impact of PI3K pathway alterations on response to immune checkpoint inhibitors in HPV-negative head and neck squamous cell carcinoma;2024-07-04

3. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma;Molecular Cancer;2024-05-16

4. Sensitization of cancer cells to paclitaxel-induced apoptosis by canagliflozin;Biochemical Pharmacology;2024-05

5. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines;BMC Complementary Medicine and Therapies;2024-04-30